Vanda Pharmaceuticals (VNDA) Earnings Date & Reports

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VNDA is expected to report earnings to fall 26.59% to -60 cents per share on August 05

Vanda Pharmaceuticals VNDA Stock Earnings Reports

Q2'26

Est.

$-0.60

Q1'26

Missed

by $0.13

Q4'25

Missed

by $0.83

Q3'25

Beat

by $0.05

Q2'25

Missed

by $0.17

The last earnings report on May 06 showed earnings per share of -81 cents, missing the estimate of -68 cents. With 228.60K shares outstanding, the current market capitalization sits at 360.51M.

View a ticker or compare two or three

Compare

VNDA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VNDA